Soterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata

LONDON, May 30, 2024 /PRNewswire/ — Soterios Pharma, a privately held clinical-stage pharmaceutical company, today announced positive topline results from its…

Related Keywords

Soterios Pharma , ,Alopecia Tool ,About Soterios ,United Kingdom Based ,Dermatol Ther ,